Grace Therapeutics, Inc. (GRCE) Insider Trading
Sector: Pharmaceuticals · Market Cap: $40M · 0 insider purchases in the last 7 days
No open market insider purchases at Grace Therapeutics, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track GRCE on your watchlist.
Start for FreeAbout Grace Therapeutics, Inc. Insider Trading
2 insiders at Grace Therapeutics, Inc. (GRCE) have purchased stock in the past 90 days, totaling $286K across 5 transactions (134,546 shares).
The most recent purchase was by 10%+ Owner Opaleye Management Inc. on September 29, 2026 — a $16K buy of 7,849 shares at $2.09, bringing his total holdings to 2,798,167 shares.
Insiders who purchased: Kohli Prashant (CEO, 1 buy totaling $214K); Opaleye Management Inc. (10%+ Owner, 4 buys totaling $72K).
This insider buying is notable given that GRCE had no recorded open market purchases in the nine months before that.
GRCE is in the Pharmaceuticals sector within the Pharmaceuticals industry with a market cap of $40M.
Track GRCE insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.